Inventor
SCANLAN THOMAS S
US28 patents
⚠️ This page may combine multiple inventors who share the name “SCANLAN THOMAS S”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV CALIFORNIA
15 patentsUS6054485AApr 25, 2000
Eye treatments using synthetic thyroid hormone compositions
UNIV CALIFORNIA37 citations94
US6555582B1Apr 29, 2003
Eye treatments using synthetic thyroid hormone compositions
UNIV CALIFORNIA32 citations91
US5883294AMar 16, 1999
Selective thyroid hormone analogs
UNIV CALIFORNIA67 citations91
US6266622B1Jul 24, 2001
Nuclear receptor ligands and ligand binding domains
UNIV CALIFORNIA28 citations89
US6107517AAug 22, 2000
Thyroid hormone analogues and methods for their preparation
UNIV CALIFORNIA25 citations89
US6831093B2Dec 14, 2004
Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof
UNIV CALIFORNIA14 citations84
US5859191AJan 12, 1999
Method for the site-specific modification of peptide alpha amines
UNIV CALIFORNIA7 citations74
US7321065B2Jan 22, 2008
Thyronamine derivatives and analogs and methods of use thereof
UNIV CALIFORNIA6 citations70
US7302347B2Nov 27, 2007
Method for creating specific, high affinity nuclear receptor pharmaceuticals
UNIV CALIFORNIA7 citations67
US7485660B2Feb 3, 2009
Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof
UNIV CALIFORNIA2 citations63
US7122579B2Oct 17, 2006
Eye treatments using synthetic thyroid hormone compositions
UNIV CALIFORNIA2 citations61
US7355079B2Apr 8, 2008
Thyronamine derivatives and analogs and methods of use thereof
UNIV CALIFORNIA3 citations59
US7645885B2Jan 12, 2010
Non-steroidal antiandrogens
UNIV CALIFORNIA2 citations53
US7947726B2May 24, 2011
Non-steroidal ligands for the glucocorticoid receptor, and compositions thereof
UNIV CALIFORNIA0 citations52
US7339079B2Mar 4, 2008
Thyronamine derivatives and analogs and methods of use thereof
UNIV CALIFORNIA0 citations50
UNIV OREGON HEALTH & SCIENCE
8 patentsUS6979750B1Dec 27, 2005
Thyronamine derivatives and analogs and methods of use thereof
UNIV OREGON HEALTH & SCIENCE12 citations82
US11104654B2Aug 31, 2021
Derivatives of sobetirome
UNIV OREGON HEALTH & SCIENCE5 citations81
US10392356B2Aug 27, 2019
Derivatives of sobetirome
UNIV OREGON HEALTH & SCIENCE8 citations81
US9701650B2Jul 11, 2017
Derivatives of sobetirome
UNIV OREGON HEALTH & SCIENCE11 citations81
US11613517B2Mar 28, 2023
Amide prodrugs of small molecule nuclear receptor modulators
UNIV OREGON HEALTH & SCIENCE4 citations70
US11325886B2May 10, 2022
Amide compounds, pharmaceutical compositions thereof, and methods of using the same
UNIV OREGON HEALTH & SCIENCE5 citations69
US11510887B2Nov 29, 2022
Sobetirome in the treatment of myelination diseases
UNIV OREGON HEALTH & SCIENCE3 citations68
US7196119B2Mar 27, 2007
Development of new selective estrogen receptor modulators
UNIV OREGON HEALTH & SCIENCE6 citations67
SCANLAN THOMAS S
3 patentsUS10226438B2Mar 12, 2019
Sobetirome in the treatment of myelination diseases
SCANLAN THOMAS S8 citations76
US8236987B2Aug 7, 2012
Selective estrogen receptor modulator compositions and methods for treatment of disease
SCANLAN THOMAS S0 citations49
US8263661B2Sep 11, 2012
Development of new selective estrogen receptor modulators
SCANLAN THOMAS S0 citations44